Boston Scientific Corporation
USD122.18
+2.83 (+2.37%)
CEO
Michael F. Mahoney
IPO Date
2020-05-22
Sector
Healthcare
Industry
Medical - Devices
Exchange
NYSE
Country
US
Open
$119.70
Prev. Close
$119.35
Day Low
$119.70
Day High
$123.27
52W Low
$97.37
52W High
$129.12
Market Cap
$175.45B
Volume
2.06M
| 15,172 |
| $16.31 |
| 10 Jan 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S-Sale | Disposed | 15,172 | $59.25 |
| 10 Jan 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M-Exempt | Disposed | 15,172 | $16.31 |
| 5 Jan 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M-Exempt | Acquired | 15,000 | $16.31 |
| 5 Jan 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S-Sale | Disposed | 15,000 | $58.40 |
| 5 Jan 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | M-Exempt | Disposed | 15,000 | $16.31 |
| 4 Jan 2024 | Mirviss Jeffrey B. | EVP&Pres, Periph Intervent | S-Sale | Disposed | 11,931 | $57.82 |
| 2 Jan 2024 | Brennan Daniel J. | EVP and CFO | M-Exempt | Acquired | 23,979 | $0.00 |
| 2 Jan 2024 | Brennan Daniel J. | EVP and CFO | F-InKind | Disposed | 8,199 | $57.81 |